Reimagining HER2 therapy: Bridging oncogene addiction and immune modulation
{{output}}
Human epidermal growth factor receptor 2 (HER2, encoded by ERBB2) is an oncogenic driver in multiple cancers. Beyond canonical signaling, HER2 remodels the tumor microenvironment by suppressing antigen presentation, enhancing checkpoint expression, and driving... ...